1. Home
  2. GEVO vs ENGN Comparison

GEVO vs ENGN Comparison

Compare GEVO & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$1.87

Market Cap

453.1M

Sector

Industrials

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.70

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
ENGN
Founded
2005
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
605.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GEVO
ENGN
Price
$1.87
$9.70
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$6.42
$22.17
AVG Volume (30 Days)
2.0M
223.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$711,000.00
N/A
Revenue This Year
$913.54
N/A
Revenue Next Year
$9.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$2.66
52 Week High
$2.95
$12.25

Technical Indicators

Market Signals
Indicator
GEVO
ENGN
Relative Strength Index (RSI) 48.11 47.58
Support Level $1.56 $8.76
Resistance Level $1.89 $10.10
Average True Range (ATR) 0.08 0.55
MACD 0.01 -0.05
Stochastic Oscillator 67.65 25.81

Price Performance

Historical Comparison
GEVO
ENGN

About GEVO Gevo Inc.

Gevo Inc is a next-generation diversified energy company committed to fueling America's future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Its technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. The business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: